Data / Form D filings / GRAIL, Inc.
GRAIL, Inc.: Form D filings
GRAIL, Inc., a biotechnology company in Menlo Park, CA, filed 8 Form D notices with the SEC between 2017 and 2025. The latest, on November 7, 2025, reports $325 million sold of a $325 million offering to 17 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1525 O'Brien Drive, Menlo Park, CA, 94025
- Phone
- (833) 694-2553
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1699031
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 7, 2025 | New notice | $324,997,989 | $324,997,989 | 17 | Oct 21, 2025 | sec.gov | |
| May 7, 2020 | Amendment | $425,000,000 | $388,407,514 | $36,592,486 | 14 | Nov 27, 2019 | sec.gov |
| Dec 12, 2019 | New notice | $250,000,000 | $125,000,000 | $125,000,000 | 1 | Nov 27, 2019 | sec.gov |
| May 25, 2018 | New notice | Indefinite | $300,000,000 | 14 | May 16, 2018 | sec.gov | |
| Jan 11, 2018 | Amendment | Indefinite | $1,214,655,040 | 59 | Feb 28, 2017 | sec.gov | |
| Nov 22, 2017 | Amendment | Indefinite | $1,211,655,039 | 58 | Feb 28, 2017 | sec.gov | |
| Apr 26, 2017 | Amendment | Indefinite | $973,248,965 | 47 | Feb 28, 2017 | sec.gov | |
| Mar 14, 2017 | New notice | Indefinite | $914,024,940 | 27 | Feb 28, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Aaron Freidin | Executive Officer | |
| Sarah Krevans | Director | |
| Gregory Summe | Director | |
| Josh Ofman | Executive Officer | |
| Steve Mizell | Director | |
| William Chase | Director | |
| Robert Ragusa | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Nov 3, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what GRAIL, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.